|
ZDHHC20 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.916000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.529640E-01 |
| Normal-vs-Stage2 |
6.263200E-01 |
| Normal-vs-Stage3 |
8.494400E-01 |
| Normal-vs-Stage4 |
7.338800E-01 |
| Stage1-vs-Stage2 |
1.756980E-01 |
| Stage1-vs-Stage3 |
1.571400E-01 |
| Stage1-vs-Stage4 |
5.423800E-01 |
| Stage2-vs-Stage3 |
7.414800E-01 |
| Stage2-vs-Stage4 |
4.914600E-01 |
| Stage3-vs-Stage4 |
6.435800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.822200E-01 |
| Normal-vs-AfricanAmerican |
1.423980E-01 |
| Normal-vs-Asian |
9.608800E-01 |
| Caucasian-vs-AfricanAmerican |
3.191000E-01 |
| Caucasian-vs-Asian |
4.755000E-01 |
| AfricanAmerican-vs-Asian |
1.781170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.824200E-01 |
| Normal-vs-Female |
1.621250E-01 |
| Male-vs-Female |
2.761600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.248400E-02 |
| Normal-vs-Age(41-60Yrs) |
8.498000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.858200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.398400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.889700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.162100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.779810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.918200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.988200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.326200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.159360E-01 |
| Classical-VS-Follicular |
1.66590000016953E-07 |
| Classical-VS-Other |
7.768300E-02 |
| Classical-VS-Normal |
1.873890E-02 |
| Tall-VS-Follicular |
7.493900E-02 |
| Tall-VS-Other |
1.843800E-01 |
| Tall-VS-Normal |
9.772600E-01 |
| Follicular-VS-Other |
6.543000E-01 |
| Follicular-VS-Normal |
1.179530E-02 |
| Other-VS-Normal |
7.189800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.135200E-01 |
| Normal-vs-N1 |
9.028600E-01 |
| N0-vs-N1 |
6.292400E-01 |
|
|
